436 results on '"Lefvert, A-K"'
Search Results
2. Polymorphisms in the CTLA‐4 gene and inhibitor development in patients with severe hemophilia A
3. CDS1 and promoter single nucleotide polymorphisms of the CTLA-4 gene in human myasthenia gravis
4. Cytokine production from colonic T cells in patients with ulcerative colitis with and without primary sclerosing cholangitis
5. Treatment of a patient with myasthenia gravis using antibodies against CD25
6. Two SNPs in the promoter region of the CTLA-4 gene affect binding of transcription factors and are associated with human myasthenia gravis
7. Human Soluble CD80 is Generated by Alternative Splicing, and Recombinant Soluble CD80 Binds to CD28 and CD152 Influencing T-cell Activation
8. The soluble forms of CD28, CD86 and CTLA-4 constitute possible immunological markers in patients with abdominal aortic aneurysm
9. A clinical and immunological study of a myasthenia gravis patient treated with infliximab
10. Raised prolactin levels in myasthenia gravis: two case reports and a study of two patient populations
11. Characterization of the expanded T-cell populations in patients with Wegenerʼs granulomatosis
12. Expression of OX40 (CD134) on CD4+ T-cells from patients with myasthenia gravis
13. β2 Adrenoceptor gene single nucleotide polymorphisms are associated with rheumatoid arthritis in northern Sweden
14. β2-Adrenergic receptor gene single-nucleotide polymorphisms are associated with rheumatoid arthritis in northern Sweden
15. Allelic polymorphisms in the repeat and promoter regions of the interleukin-4 gene and malaria severity in Ghanaian children
16. Circulating CD4+CD25+ and CD4+CD25− T Cells in Myasthenia Gravis and in Relation to Thymectomy
17. Circulating CD4+CD25+ and CD4+CD25− T Cells in Myasthenia Gravis
18. Polymorphisms in Interleukin-1β and Interleukin-1 Receptor Antagonist Genes and Malaria in Ghanaian Children
19. Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis
20. Regulation of Surface and Intracellular Expression of CTLA-4 on Human Peripheral T Cells
21. Introduction
22. Heterogeneity of autoantibodies against cardiolipin and oxidatively modified LDLs revealed by human monoclonal antibodies
23. β2-adrenergic receptor gene polymorphisms in myasthenia gravis (MG)
24. Anti-cardiolipin antibodies and circulating immune complexes in type 1 diabetes mellitus: increased prevalence and relation to vascular complications
25. CTLA4 is expressed on mature dendritic cells derived from human monocytes and influences their maturation and antigen presentation
26. Abnormal T cell receptor V gene usage in myasthenia gravis: prevalence and characterization of expanded T cell populations
27. Treatment of myasthenia gravis with methylprednisolone pulse: a double blind study
28. Myasthenia Gravis with Thymic Hyperplasia Is Associated with Polymorphisms in the Tumor Necrosis Factor Region
29. HLA-DQ ASSOCIATIONS AND T-CELL RECEPTOR V-GENE USAGE IN PERIPHERAL BLOOD OF SWEDISH MYASTHENIA GRAVIS PATIENTS
30. Enrichment of antibodies against phospholipids in circulating immune complexes (CIC) in the anti-phospholipid syndrome (APLS)
31. A bias in the αβ T cell receptor variable region gene usage in Takayasu's arteritis
32. TAP polymorphisms in Swedish myasthenia gravis patients
33. Anti-Idiotypic T Cells in Early Stages of Myasthenia Gravis: Increase in the Number and Prevalence Correlated to Clinical Improvement in Patients
34. 3. Reply: Lipoproteins, anticardiolipin autoantibodies and artherosclerosis
35. Idiotype-induced T cell stimulation requires antigen presentation in association with HLA-DR molecules
36. Prevalence of antibodies to cardiolipin in chronic ITP and reactivity with platelet membranes
37. Induction of Human Cytotoxic T Lymphocytes by Oxidized Low Density Lipoproteins
38. T and B lymphocytes reacting with the extracellular loop of theβ2-adrenergic receptor (β2AR) are present in the peripheral blood of patients with myasthenia gravis
39. Presynaptic Membrane Receptor-Reactive T Lymphocytes in Myasthenia Gravis
40. A CTLA-4 gene polymorphism at position −318 in the promoter region affects the expression of protein
41. New Evidence for True Immunopharmacologic Blockade in Myasthenia Gravis
42. Mab 17-1A Used for Therapy of Patients with Metastatic Colorectal Carcinomas
43. Residual insulin production, glycaemic control and prevalence of microvascular lesions and polyneuropathy in long-term Type 1 (insulin-dependent) diabetes mellitus
44. Anti-Idiotypic Monoclonal Antibodies Against Myasthenic Antibodies
45. New Evidence for True Immunopharmacologic Blockade in Myasthenia Gravis
46. Overexpression of select T cell receptor V beta gene families within CD4+ and CD8+ T cell subsets of myasthenia gravis patients: a role for superantigen(s)?
47. beta2 Adrenoceptor gene single nucleotide polymorphisms are associated with rheumatoid arthritis in northern Sweden.
48. Beta2-adrenergic receptor gene single-nucleotide polymorphisms are associated with rheumatoid arthritis in northern Sweden.
49. Allelic polymorphisms in the repeat and promoter regions of the interleukin-4 gene and malaria severity in Ghanaian children
50. CTLA4 is expressed on mature dendritic cells derived from human monocytes and influences their maturation and antigen presentation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.